LA JOLLA, CA--(Marketwire - February 11, 2008) - Transdel Pharmaceuticals, Inc. (OTCBB: TDLP), a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically targeted medications, announced today that the Company will present at the ROTH Capital Partners 20th Annual OC Growth Stock Conference on Thursday, February 21, 2008 at 12:00 p.m. Pacific Time. The conference will be held at the Ritz Carlton Hotel in Laguna Niguel, California.
